IQE

Current Thesis

The two-year binary has resolved. On 2026-04-27 IQE concluded its strategic review by terminating all whole-group sale talks and instead taking an £81m strategic investment led by MACOM (an existing customer), completed alongside FY2025 results on 2026-05-28. The going-concern/dilution overhang that capped the tape for two years is gone: HSBC RCF repaid, CLNs redeemed, clean audit to June 2027. The story flips from a dying handset-epiwafer supplier to an InP-for-AI-datacenter optical name — Photonics +15% in FY2025, FY2026 guided >20% revenue growth with EBITDA inflecting off a £3.2m base. This is now a legacy-pivot re-rate (archetype 5 → 4), NOT a pre-catalyst gamble. But the relief pop already ran in May; both catalysts (raise + results) are behind us and there is no hard catalyst in the next 30 days. MATURING setup — the edge is buying a pullback toward the 19.8p raise level on a confirmed higher-low, not chasing a digested event.

Bull Case

• Balance-sheet overhang removed (RNS 2026-04-27 / 2026-05-28): £81m raise = £30m MACOM equity at 19.8p (151,515,151 shares) + £15m MACOM zero-coupon convertible + £22.8m noteholder reinvestment + ~£13m placing/retail. Net £27.9m inflow after repaying the $35m HSBC RCF. Going-concern confirmed under severe-downside to June 2027. The single biggest reason this name was un-ownable is now off the table.
• MACOM is a strategic anchor, not a passive placer (RNS 2026-04-27): an existing customer took a stake + 2 NED seats + a convertible. That converts IQE from forced-seller to strategically-backed supplier and seeds genuine future-takeout optionality (MACOM/MTSI commentary on IQE supply is now a direct tell).
• Photonics is already the growth engine (FY2025 RNS 2026-05-28): £57.1m revenue +15% YoY, segment EBITDA £8.4m (up from £5.84m), now ~59% of group revenue. This is the InP/datacenter-optical line, and it is accelerating while the company shrinks the dead wood.
• FY2026 guide is an inflection, not a grind (RNS 2026-05-28): ">20% revenue growth" + "high-single to low-double-digit adjusted EBITDA" off a £3.2m FY2025 base = non-linear operating leverage if delivered. Driver explicitly named as InP for 800G/1.6T datacenter/AI optical.
• Sector pull confirmed by peers: COHR guided 800G datacom revenue +60% QoQ (FQ2 call 2026-02-05); LITE reiterated 1.6T ramp into H2 2026 (2026-02-11). IQE is one of two scaled merchant InP epi suppliers feeding that transceiver chain.

Bear Case

• Wireless is still structurally broken (FY2025 RNS 2026-05-28): £40.1m revenue -40% YoY, segment EBITDA collapsed to £6.6m from £16.2m. Still ~41% of the group. In-sourcing (Apple/Lumentum VCSEL, Coherent's own InP) is permanent, not cyclical — this drag does not "come back."
• The pivot has barely any profit yet: group adjusted EBITDA only £3.2m on £97.3m revenue (3% margin), reported loss before tax £37.0m (FY2025 RNS 2026-05-28). This is a fragile turnaround being priced as a growth compounder.
• Dilution + a low clearing price (RNS 2026-04-27/05-28): ~330m+ new shares issued on a 972.9m base (~34% dilution) at 19.8p — a low anchor and a fresh ceiling of supply that institutions can sell into strength.
• The takeout-premium branch is dead (RNS 2026-04-27): whole-group sale talks were terminated. Longs who were playing a sale premium have nothing left but execution — and execution risk on a 3%-margin AIM name is high.
• Easy money already paid out: the relief rally ran in May 2026 post-raise/results. With no hard catalyst in the next 30 days, a fresh entry here is chasing a digested event into thin AIM liquidity.

Setup & Price Structure

• Ticker discipline: trade IQE.L (London AIM, pence) ONLY. IQEPY ADR is illiquid; US "IQE" tickers are unrelated entities — do not confuse.
• Structural anchor = 19.8p (strategic-raise price, 2026-04-27/05-28). This is MACOM's and the institutions' cost basis. Above it = re-rate intact; a weekly close below 19.8p on volume = floor broken, institutions underwater, thesis dead.
• Cap structure post-raise: ~1.3bn shares; market cap ≈ £250–260m near the raise level; net debt cut by ~£28m net inflow toward roughly neutral; EV/FY2026e sales ≈ ~2x. Not cheap for a 3%-margin base — you are paying for the mix shift.
• DATA CAVEAT — verify before sizing: some aggregator feeds showed ~47–54p prints in mid-May 2026, which is inconsistent with a 19.8p raise and is almost certainly a feed/share-line artifact. There is no reliable engine price feed this cycle. Operator MUST confirm live IQE.L spot, 20-EMA, and 50/200-DMA before any size.
• Volatility regime: 10–15% gaps on RNS are routine on AIM — limit orders only, never market orders.
• Entry plan: for IQE specifically this is MATURING, not ACCELERATING (the catalysts just passed). Buy a pullback toward 19.8p with a confirmed higher-low, or wait for the H1 2026 interim execution proof (~Sept). No chase, LOW-probe sizing only.

Catalyst Calendar (next 30 days)

• 2026-04-27 (DONE) — Strategic review concluded: remain independent, whole-group talks terminated, MACOM strategic investment agreed.
• 2026-05-28 (DONE) — FY2025 results + £81m raise completion RNS. Revenue £97.3m, adj EBITDA £3.2m, FY2026 guide >20% growth.
• ~2026-06 (est.) — Admission of new shares / MACOM 2 NED appointments effective; AGM possible (historically June). Procedural, not a re-rating event.
• No confirmed hard binary in the next 30 days → catalyst_date null. Watch only for an unscheduled trading update or any MACOM/MTSI conference commentary referencing IQE supply.
• ~2026-09 (est.) — H1 2026 interim results: the FIRST execution checkpoint on the >20% FY2026 guide and the InP ramp. This is the next real trade trigger, outside the 30-day window.

What Would Change Our Mind

• Upgrade to MEDIUM/HIGH: a clean pullback that holds above 19.8p with a higher-low, then H1 2026 interims (~Sept) confirming Photonics/InP growth and EBITDA inflection — OR a trading update raising the >20% FY2026 guide — OR MACOM moving toward a full takeout. Any of these turns the probe into a real position.
• Invalidate / stay out (hard): weekly close below the 19.8p raise price on >1.5x average volume; FY2026 >20% growth guide cut in any update; Photonics revenue down half-on-half at H1; or any new going-concern/covenant language contradicting the clean June-2027 opinion.
• If held and it breaks: archetype 4 → trim on a weekly close below the 20-EMA or below 19.8p; full exit on a guide cut or going-concern language — cut hard, do not ride an AIM micro-cap down. This is NOT archetype 6, so there is no auto-RSI trim; let a confirmed winner run unless the narrative actually breaks.

Correlation Notes

• Primary complex — datacenter/AI optical (InP): read-through to COHR, LITE, FN (Fabrinet), AAOI and the MRVL/NVDA optical-demand chain. IQE sits upstream as epi-wafer supply, so it tends to lag transceiver-maker order signals — use peer guides (COHR/LITE 800G/1.6T) as the leading tell.
• Wireless drag: correlates with the smartphone/RF cycle — SWKS, QRVO, Apple build rates. Weakness here is the bear anchor and is largely decoupled from the bull (optical) leg.
• GaN power optionality: ties loosely to NVTS (Navitas) and Infineon power-density narrative; secondary, not a sizing driver.
• Idiosyncratic AIM/£ name: low intraday correlation to SPY/QQQ — this trades on RNS flow and sector read-through, not US index beta. MACOM (MTSI) is now a direct strategic correlate — its commentary on IQE supply or its convertible economics is a first-order signal.

Bottom Line

The setup is genuinely better than the old "no-edge binary" frame — de-risked balance sheet, strategic MACOM anchor, an accelerating InP/AI-optical theme, and a >20% FY2026 guide. But the easy catalyst money already paid out in May, wireless is still bleeding, and there is no near-term trigger. LOW conviction on a fresh entry at the post-pop print; the disciplined trade is a pullback-to-19.8p probe or waiting for the ~Sept H1 execution proof. Verify live spot first — the price context is missing and one feed is clearly wrong.